Výsledky vyhledávání - "Prayashi Ghelani"

A phase 3 open-label, randomized multicenter study to evaluate efficacy and safety of secukinumab in pediatric patients with moderate to severe plaque psoriasis: 24-week results

Autor: Pascal Forrer, Prayashi Ghelani, Rafal Mazur, Manmath Patekar, LindaAnn Wraith, Deborah L. Keefe, Vivian Laquer, Külli Kingo, John Browning, Jacek C Szepietowski, Nina Magnolo, Adam Reich

Publikováno v: Journal of the American Academy of Dermatology. 86(1)

Psoriasis affects 0.13%-2.1% of children and adolescents. Despite a high unmet need, the current treatment options approved for pediatric psoriasis are limited.To evaluate the efficacy and safety of 2 secukinumab dosage regimens (low dose: 75/75/150

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d947aa4cb1f72e25eb29e65aca82b96f
https://pubmed.ncbi.nlm.nih.gov/34555481

Zobrazit plný text záznamu

26860 Secukinumab treatment demonstrated high efficacy and safety in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from a randomized trial

Autor: Külli Kingo, Prayashi Ghelani, Vivian Laquer, Deborah L. Keefe, John Browning, Pascal Forrer, Nina Magnolo, Rafal Mazur, Manmath Patekar, Adam Reich, Jacek C Szepietowski

Publikováno v: Journal of the American Academy of Dermatology. 85:AB119

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::430e39eabdde73cbe5024c9b2948ab7b
https://doi.org/10.1016/j.jaad.2021.06.493

Zobrazit plný text záznamu

Health Resource Utilization Associated with Skeletal-Related Events in Patients with Advanced Prostate Cancer: A European Subgroup Analysis from an Observational, Multinational Study

Autor: Herbert Hoefeler, E. Thomas, Diana Lüftner, Cristina Garzon-Rodriguez, Amit Bahl, Prayashi Ghelani, Vito Lorusso, John Ashcroft, R. Wei, Ignacio Duran, Guy Hechmati

Publikováno v: Journal of Clinical Medicine
Volume 3
Issue 3
Pages 883-896
Journal of Clinical Medicine, Vol 3, Iss 3, Pp 883-896 (2014)

This study aimed to increase the understanding of health resource utilization (HRU) associated with skeletal-related events (SREs) occurring in patients with bone metastases secondary to advanced prostate cancer. A total of 120 patients from Germany,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc25b31696c95de5186f2762743ffaa8
http://europepmc.org/articles/PMC4449648

Zobrazit plný text záznamu

Treatment Satisfaction in Postmenopausal Women Previously Treated with Bisphosphonates Who Transitioned to Denosumab Vs Ibandronate Therapy in an Open-Label Study

Autor: Santiago Palacios, Irene Agodoa, Hema Viswanathan, Prayashi Ghelani, Irene Ferreira, Cynthia O’Malley, Rachel B. Wagman, Sydney Bonnick, IOLASCON, Giovanni

Background/Purpose: Higher treatment satisfaction is associated with greater persistence with osteoporosis therapy in postmenopausal women (Barrett-Connor OI 2012). Greater satisfaction has been reported with subcutaneous injections of denosumab comp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3977::3addc791b4f586fb1b49f0ee9349e65f
http://hdl.handle.net/11591/222922

Zobrazit plný text záznamu

In postmenopausal women previously treated with an oral bisphosphonate and at higher risk of fracture, denosumab significantly increases bone mineral density compared with ibandronate and risedronate

Autor: P. Dakin, Prayashi Ghelani, Henry G. Bone, P.R. Ho, Irene Ferreira, Michael A. Bolognese, Christian Roux, Rachel B. Wagman, Jacques P. Brown, Sydney Lou Bonnick, den Bergh Joop van, Christopher Recknor

Publikováno v: Bone Abstracts.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d5412f075a1f6006a261c10603050ce7
https://doi.org/10.1530/boneabs.3.pp357

Zobrazit plný text záznamu

Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy : a Randomized open-label trial

Autor: Santiago Palacios, Rachel B. Wagman, S. Siddhanti, Edward Czerwiński, Sydney Lou Bonnick, Jesse W. Hall, Neil Binkley, Alfred H. Moffett, Claude-Laurent Benhamou, Michael A. Bolognese, Irene Ferreira, Henry G. Bone, Prayashi Ghelani, Chris Recknor

To compare the efficacy and safety of denosumab to ibandronate in postmenopausal women with low bone mineral density (BMD) previously treated with a bisphosphonate.In a randomized, open-label study, postmenopausal women received 60 mg denosumab subcu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d62c4cbf7206a1ffe8bec90537949a92
https://ruj.uj.edu.pl/xmlui/handle/item/95645

Zobrazit plný text záznamu

Health resource utilization associated with skeletal-related events in patients with advanced breast cancer: results from a prospective, multinational observational study

Autor: R. Wei, John Ashcroft, V. Lorusso, Ignacio Duran, Amit Bahl, Diana Lüftner, Cristina Garzon-Rodriguez, Guy Hechmati, Herbert Hoefeler, Prayashi Ghelani, E. Thomas

Publikováno v: SpringerPlus

Patients with breast cancer and bone metastases often experience skeletal complications (skeletal-related events [SREs]: pathologic fracture, radiation to bone, surgery to bone or spinal cord compression). Prospective data on the health resource burd

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8419ae09a02dd895b5c9b98830e990b1

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání